Since FDA approved Semaglutide for the treatment of obesity, GLP-1RA has occupied the majority of the market for the treatment of obesity. As more and more people use GLP-1RA, including Semaglutide, they found it in addition to helping with weight loss and adjusting the body’s metabolic level, GLP-1RA also affects the user’s mental health, including reducing anxiety and controlling a …